Jazz Pharmaceuticals plc 10-K for FY2023
Jazz Pharmaceuticals plc (JAZZ)
10-K
2024-02-28
For: 2023-12-31
View Original
Added on
April 08, 2026
About this 10-K
Jazz Pharmaceuticals plc filed this 10-K on February 28, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.83B
- up 4.8% from $3.66B a year earlier
- Net income
- $414.83M
- compared with a net loss of $224.06M a year earlier
- Diluted EPS
- $6.10
- compared with -$3.58 a year earlier